BR0306730A - Processo e intermediários para agentes antidiabéticos de piridazinona - Google Patents

Processo e intermediários para agentes antidiabéticos de piridazinona

Info

Publication number
BR0306730A
BR0306730A BR0306730-0A BR0306730A BR0306730A BR 0306730 A BR0306730 A BR 0306730A BR 0306730 A BR0306730 A BR 0306730A BR 0306730 A BR0306730 A BR 0306730A
Authority
BR
Brazil
Prior art keywords
diabetic
pyridazinone
intermediates
antidiabetic agents
relates
Prior art date
Application number
BR0306730-0A
Other languages
English (en)
Inventor
Norma Jacqueline Tom
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of BR0306730A publication Critical patent/BR0306730A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

"PROCESSO E INTERMEDIáRIOS PARA AGENTES ANTIDIABéTICOS DE PIRIDAZINONA". A presente invenção refere-se a um processo para preparar inibidores de aldose redutase de piridazinona que são úteis na prevenção e/ou tratamento de complicações diabéticas tais como neuropatia diabética, retinopatia diabética, nefropatia diabética, cardiomiopatia diabética, microangiopatia diabética e macroangiopatia diabética nos mamíferos. A invenção também refere-se a novos intermediários úteis na preparação daqueles inibidores de aldose redutase.
BR0306730-0A 2002-01-09 2003-01-03 Processo e intermediários para agentes antidiabéticos de piridazinona BR0306730A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34767902P 2002-01-09 2002-01-09
PCT/IB2003/000013 WO2003057691A1 (en) 2002-01-09 2003-01-03 Process and intermediates for pyridazinone antidiabetic agents

Publications (1)

Publication Number Publication Date
BR0306730A true BR0306730A (pt) 2004-12-21

Family

ID=23364775

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0306730-0A BR0306730A (pt) 2002-01-09 2003-01-03 Processo e intermediários para agentes antidiabéticos de piridazinona

Country Status (22)

Country Link
US (1) US6759534B2 (pt)
EP (1) EP1463725B1 (pt)
JP (1) JP2005514421A (pt)
KR (1) KR100604502B1 (pt)
CN (1) CN1269814C (pt)
AR (1) AR038267A1 (pt)
AT (1) ATE302201T1 (pt)
AU (1) AU2003200847A1 (pt)
BR (1) BR0306730A (pt)
CA (1) CA2472331A1 (pt)
DE (1) DE60301324T2 (pt)
DK (1) DK1463725T3 (pt)
ES (1) ES2246464T3 (pt)
HU (1) HUP0500031A2 (pt)
IL (1) IL162594A0 (pt)
MX (1) MXPA04005646A (pt)
PL (1) PL371258A1 (pt)
PT (1) PT1463725E (pt)
RU (1) RU2278116C2 (pt)
TW (1) TWI250980B (pt)
WO (1) WO2003057691A1 (pt)
ZA (1) ZA200404798B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2442476A1 (en) * 2001-03-30 2002-10-10 Pfizer Products Inc. Pyridazinone aldose reductase inhibitors
CN103333144B (zh) * 2013-06-17 2014-12-10 温州大学 一种2-硫基-3-卤代苯并呋喃化合物及其合成方法和用途
CN105732552B (zh) * 2016-04-12 2017-12-01 天津师范大学 2位或3‑位硫代苯并呋喃化合物的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3328770A1 (de) * 1983-08-10 1985-02-28 Basf Ag, 6700 Ludwigshafen Pyridazinon-derivate, verfahren zu ihrer herstellung und ihre verwendung als fungizide
CA2442476A1 (en) * 2001-03-30 2002-10-10 Pfizer Products Inc. Pyridazinone aldose reductase inhibitors

Also Published As

Publication number Publication date
ZA200404798B (en) 2006-02-22
DE60301324T2 (de) 2006-05-24
JP2005514421A (ja) 2005-05-19
PL371258A1 (en) 2005-06-13
TW200302098A (en) 2003-08-01
ES2246464T3 (es) 2006-02-16
CN1615307A (zh) 2005-05-11
RU2278116C2 (ru) 2006-06-20
HUP0500031A2 (hu) 2005-04-28
CA2472331A1 (en) 2003-07-17
AR038267A1 (es) 2005-01-12
RU2004121026A (ru) 2006-01-10
EP1463725B1 (en) 2005-08-17
US20030162969A1 (en) 2003-08-28
TWI250980B (en) 2006-03-11
EP1463725A1 (en) 2004-10-06
WO2003057691A1 (en) 2003-07-17
PT1463725E (pt) 2005-10-31
ATE302201T1 (de) 2005-09-15
US6759534B2 (en) 2004-07-06
AU2003200847A1 (en) 2003-07-24
IL162594A0 (en) 2005-11-20
HK1072598A1 (en) 2005-09-02
CN1269814C (zh) 2006-08-16
KR20040072710A (ko) 2004-08-18
KR100604502B1 (ko) 2006-07-25
MXPA04005646A (es) 2004-12-06
DE60301324D1 (de) 2005-09-22
DK1463725T3 (da) 2005-11-21

Similar Documents

Publication Publication Date Title
BRPI0510593A (pt) composições para afetar a perda de peso
BR0013081A (pt) Pirimidino-2,4,6-trionas inibidoras de metaloproteinases
ATE541928T1 (de) Inhibitoren der untereinheit 2 der ribonukleotidreduktase und ihre verwendungen
BRPI0517423A (pt) composto, composição farmacêutica, método para o tratamento ou prevenção de distúrbios neurológicos e psiquiátricos associados com disfunção do glutamato em um animal, e, uso em um composto
BR0312575A (pt) Moduladores do receptor de glicocorticóides
DOP2002000545A (es) Moléculas pequeñas para el tratamiento del crecimiento celular anormal
BRPI0512987A (pt) processo para preparar compostos, composto, uso do mesmo, e, material de revestimento termicamente curável, curável por radiação ou de cura dupla
DE59701369D1 (de) Thermisch härtbare, wässrige zusammensetzungen
GT200100016A (es) Pirido[2,3,-d]pirimidin-2,7-diaminas inhibidoras de cinasas.
BRPI0314133A8 (pt) Processo para isolamento de epotilona b, métodos para cultivo de microorganismo que produza epotilona a ou b e para purifiação de apotilona
BRPI0408888A (pt) processo para a preparação de derivados de 1-n-(fenil)-2-n-(fenil) pirrolidina-1,2-dicarboxamida e derivados de ácido 1-(fenilcarbamoil) pirrolidina-2-carboxìlico como intermediários
BRPI0108990B8 (pt) processo para preparação de derivados de pirimidona com atividade antifungos
BR0100982A (pt) Processo para a preparação de derivados deresorcinol
BR9808854A (pt) Processo para preparação de um composto, e, composto
BRPI0416479A (pt) derivado quinazolina, composição farmacêutica, e, processo para a preparação de um derivado de quinazolina
BR9814855A (pt) Processo para tratamento antimicrobiano de microrganismos e/ou vìrus, e, composição antimicrobiana.
BRPI0712889A8 (pt) composto, processo para a preparação de um composto, composto intermediário, e, composição farmacêutica.
BRPI0416030A (pt) pirido-7-pirimidin-7-onas substituìdas com hidroxialquila
BR0110689A (pt) Composição fungicida, e, métodos para intensificar a atividade fungicida de etaboxam, e para controlar fitopatógenos indesejados
CL2004000804A1 (es) Procedimiento de preparacion en una sola etapa de n-(n'-glicilo substituida)-2-cianopirrolidina.
BRPI0606358A2 (pt) uso de pelo menos um aminoditiol, processo e kit para a deformação permanente dos cabelos e aminotióis
BR0306730A (pt) Processo e intermediários para agentes antidiabéticos de piridazinona
BRPI0412910A (pt) derivados de nicotinamida úteis como inibidores de pde4
BRPI0410512A (pt) processo que compreende o contato de po3g e composição que compreende (i) po3g
BR0011996A (pt) Preparação de piperidin-4-onas substituìdas

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6O E 7O ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2047 DE 30/03/2010.